327 related articles for article (PubMed ID: 12421917)
1. Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells.
Noessner E; Gastpar R; Milani V; Brandl A; Hutzler PJ; Kuppner MC; Roos M; Kremmer E; Asea A; Calderwood SK; Issels RD
J Immunol; 2002 Nov; 169(10):5424-32. PubMed ID: 12421917
[TBL] [Abstract][Full Text] [Related]
2. Melanoma-reactive class I-restricted cytotoxic T cell clones are stimulated by dendritic cells loaded with synthetic peptides, but fail to respond to dendritic cells pulsed with melanoma-derived heat shock proteins in vitro.
Fleischer K; Schmidt B; Kastenmüller W; Busch DH; Drexler I; Sutter G; Heike M; Peschel C; Bernhard H
J Immunol; 2004 Jan; 172(1):162-9. PubMed ID: 14688322
[TBL] [Abstract][Full Text] [Related]
3. Heat shock protein 70: role in antigen presentation and immune stimulation.
Milani V; Noessner E; Ghose S; Kuppner M; Ahrens B; Scharner A; Gastpar R; Issels RD
Int J Hyperthermia; 2002; 18(6):563-75. PubMed ID: 12537755
[TBL] [Abstract][Full Text] [Related]
4. Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells.
Castelli C; Ciupitu AM; Rini F; Rivoltini L; Mazzocchi A; Kiessling R; Parmiani G
Cancer Res; 2001 Jan; 61(1):222-7. PubMed ID: 11196165
[TBL] [Abstract][Full Text] [Related]
5. Enhanced immunogenicity of heat shock protein 70 peptide complexes from dendritic cell-tumor fusion cells.
Enomoto Y; Bharti A; Khaleque AA; Song B; Liu C; Apostolopoulos V; Xing PX; Calderwood SK; Gong J
J Immunol; 2006 Nov; 177(9):5946-55. PubMed ID: 17056519
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific immune responses.
Nouri-Shirazi M; Banchereau J; Bell D; Burkeholder S; Kraus ET; Davoust J; Palucka KA
J Immunol; 2000 Oct; 165(7):3797-803. PubMed ID: 11034385
[TBL] [Abstract][Full Text] [Related]
7. Hybrids of dendritic cells and tumor cells generated by electrofusion simultaneously present immunodominant epitopes from multiple human tumor-associated antigens in the context of MHC class I and class II molecules.
Parkhurst MR; DePan C; Riley JP; Rosenberg SA; Shu S
J Immunol; 2003 May; 170(10):5317-25. PubMed ID: 12734382
[TBL] [Abstract][Full Text] [Related]
8. CD1 molecules efficiently present antigen in immature dendritic cells and traffic independently of MHC class II during dendritic cell maturation.
Cao X; Sugita M; Van Der Wel N; Lai J; Rogers RA; Peters PJ; Brenner MB
J Immunol; 2002 Nov; 169(9):4770-7. PubMed ID: 12391186
[TBL] [Abstract][Full Text] [Related]
9. Melanoma-associated antigen tyrosinase but not Melan-A/MART-1 expression and presentation dissociate during the heat shock response.
Milani V; Frankenberger B; Heinz O; Brandl A; Ruhland S; Issels RD; Noessner E
Int Immunol; 2005 Mar; 17(3):257-68. PubMed ID: 15642953
[TBL] [Abstract][Full Text] [Related]
10. Human heat shock protein 70 enhances tumor antigen presentation through complex formation and intracellular antigen delivery without innate immune signaling.
Bendz H; Ruhland SC; Pandya MJ; Hainzl O; Riegelsberger S; Braüchle C; Mayer MP; Buchner J; Issels RD; Noessner E
J Biol Chem; 2007 Oct; 282(43):31688-702. PubMed ID: 17684010
[TBL] [Abstract][Full Text] [Related]
11. Dendritic-tumor fusion cells derived heat shock protein70-peptide complex has enhanced immunogenicity.
Zhang Y; Zhang Y; Chen J; Liu Y; Luo W
PLoS One; 2015; 10(5):e0126075. PubMed ID: 25961716
[TBL] [Abstract][Full Text] [Related]
12. Cross-Presentation of the Oncofetal Tumor Antigen 5T4 from Irradiated Prostate Cancer Cells--A Key Role for Heat-Shock Protein 70 and Receptor CD91.
Salimu J; Spary LK; Al-Taei S; Clayton A; Mason MD; Staffurth J; Tabi Z
Cancer Immunol Res; 2015 Jun; 3(6):678-88. PubMed ID: 25678582
[TBL] [Abstract][Full Text] [Related]
13. Bacterial heat shock proteins promote CD91-dependent class I MHC cross-presentation of chaperoned peptide to CD8+ T cells by cytosolic mechanisms in dendritic cells versus vacuolar mechanisms in macrophages.
Tobian AA; Canaday DH; Boom WH; Harding CV
J Immunol; 2004 May; 172(9):5277-86. PubMed ID: 15100266
[TBL] [Abstract][Full Text] [Related]
14. A new purification method for enhancing the immunogenicity of heat shock protein 70-peptide complexes.
Gao Y; Chen X; Gao W; Yang Y; Ma H; Ren X
Oncol Rep; 2012 Dec; 28(6):1977-83. PubMed ID: 23007635
[TBL] [Abstract][Full Text] [Related]
15. Tumor-derived heat shock protein 70-pulsed dendritic cells elicit tumor-specific cytotoxic T lymphocytes (CTLs) and tumor immunity.
Ueda G; Tamura Y; Hirai I; Kamiguchi K; Ichimiya S; Torigoe T; Hiratsuka H; Sunakawa H; Sato N
Cancer Sci; 2004 Mar; 95(3):248-53. PubMed ID: 15016325
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis.
Jenne L; Arrighi JF; Jonuleit H; Saurat JH; Hauser C
Cancer Res; 2000 Aug; 60(16):4446-52. PubMed ID: 10969791
[TBL] [Abstract][Full Text] [Related]
17. Heat shock proteins 70 and 60 share common receptors which are expressed on human monocyte-derived but not epidermal dendritic cells.
Lipsker D; Ziylan U; Spehner D; Proamer F; Bausinger H; Jeannin P; Salamero J; Bohbot A; Cazenave JP; Drillien R; Delneste Y; Hanau D; de la Salle H
Eur J Immunol; 2002 Feb; 32(2):322-32. PubMed ID: 11807771
[TBL] [Abstract][Full Text] [Related]
18. Efficient CTL productivity of modified fusion cells by increase of heat shock protein 70.
Koide T; Iinuma H; Fukushima R
Oncol Rep; 2009 Mar; 21(3):737-46. PubMed ID: 19212634
[TBL] [Abstract][Full Text] [Related]
19. Differential capacity of chaperone-rich lysates in cross-presenting human endogenous and exogenous melanoma differentiation antigens.
Bleifuss E; Bendz H; Sirch B; Thompson S; Brandl A; Milani V; Graner MW; Drexler I; Kuppner M; Katsanis E; Noessner E; Issels RD
Int J Hyperthermia; 2008 Dec; 24(8):623-37. PubMed ID: 18608582
[TBL] [Abstract][Full Text] [Related]
20. Enhanced susceptibility to cytotoxic T lymphocytes without increase of MHC class I antigen expression after conditional overexpression of heat shock protein 70 in target cells.
Dressel R; Lübbers M; Walter L; Herr W; Günther E
Eur J Immunol; 1999 Dec; 29(12):3925-35. PubMed ID: 10602000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
